Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (61-70 of 350) with videos related to

Pageof 35
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 11, 1998
Local cutaneous necrotizing lesions associated with interferon injectionsU Krainick, H Kantarjian, S Broussard, et al.
Cancer|April 1, 1991
Extramedullary blast crisis in a patient with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic remissionS O'Brien, R Witt, M Talpaz, et al.
Cytokines and Molecular Therapy|September 1, 1995
Interleukin-1 and its inhibitors: a biologic and therapeutic model for the role of growth regulatory factors in leukemiasR Kurzrock, M Wetzler, Z Estrov, et al.
Hematopathology and Molecular Hematology|January 1, 1997
Effects of interferon-alpha therapy on lymphocyte subpopulations in patients with chronic myeloid leukemiaS Sacchi, J Cortes, H Kantarjian, et al.
Leukemia|November 9, 2000
Cytoplasmic and nuclear localization of the 130 and 160 kDa Bcr proteinsE Laurent, M Talpaz, M Wetzler, et al.
Gene|March 9, 1996
Chromatin nucleoprotein complexes containing tightly bound c-abl, p53 and bcl-2 gene sequences: correlation with progression of chronic myelogenous leukemiaN L Nicolson, M Talpaz, G L Nicolson
Seminars in Hematology|July 1, 1990
Update on therapeutic options for chronic myelogenous leukemiaM Talpaz, H Kantarjian, R Kurzrock, et al.
Blood|April 15, 1996
Treatment of myelogenous leukemia: current status and investigational optionsH M Kantarjian, S O'Brien, P Anderlini, et al.
British Journal of Haematology|October 1, 1991
Interferon alpha in the therapy of CMLM Talpaz, H Kantarjian, R Kurzrock, et al.
Bailliere'S Clinical Haematology|June 1, 1997
Natural history and staging of chronic myelogenous leukaemiaJ Cortes, H M Kantarjian, S Giralt, et al.
Pageof 35

Showing results (61-70 of 350) with videos related to

Sort By:
Pageof 35
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 11, 1998
Local cutaneous necrotizing lesions associated with interferon injectionsU Krainick, H Kantarjian, S Broussard, et al.
Cancer|April 1, 1991
Extramedullary blast crisis in a patient with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic remissionS O'Brien, R Witt, M Talpaz, et al.
Cytokines and Molecular Therapy|September 1, 1995
Interleukin-1 and its inhibitors: a biologic and therapeutic model for the role of growth regulatory factors in leukemiasR Kurzrock, M Wetzler, Z Estrov, et al.
Hematopathology and Molecular Hematology|January 1, 1997
Effects of interferon-alpha therapy on lymphocyte subpopulations in patients with chronic myeloid leukemiaS Sacchi, J Cortes, H Kantarjian, et al.
Leukemia|November 9, 2000
Cytoplasmic and nuclear localization of the 130 and 160 kDa Bcr proteinsE Laurent, M Talpaz, M Wetzler, et al.
Gene|March 9, 1996
Chromatin nucleoprotein complexes containing tightly bound c-abl, p53 and bcl-2 gene sequences: correlation with progression of chronic myelogenous leukemiaN L Nicolson, M Talpaz, G L Nicolson
Seminars in Hematology|July 1, 1990
Update on therapeutic options for chronic myelogenous leukemiaM Talpaz, H Kantarjian, R Kurzrock, et al.
Blood|April 15, 1996
Treatment of myelogenous leukemia: current status and investigational optionsH M Kantarjian, S O'Brien, P Anderlini, et al.
British Journal of Haematology|October 1, 1991
Interferon alpha in the therapy of CMLM Talpaz, H Kantarjian, R Kurzrock, et al.
Bailliere'S Clinical Haematology|June 1, 1997
Natural history and staging of chronic myelogenous leukaemiaJ Cortes, H M Kantarjian, S Giralt, et al.
Pageof 35